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A B S T R A C T
Probiotics are microorganisms that provide health beneﬁts when consumed. In animals, probiotics reverse gut
microbiome-related alterations in depression-like symptoms, in cognition, and in hormonal stress response.
However, in humans, a causal understanding of the gut-brain link in emotion and cognition is lacking.
Additionally, whether the eﬀects of probiotics on neurocognition are visible only in presence of stress, remains
unclear. We investigated the eﬀects of a multispecies probiotic (Ecologic®Barrier) on speciﬁc neurocognitive
measures of emotion reactivity, emotion regulation, and cognitive control using fMRI. Critically, we also tested
whether probiotics can buﬀer against the detrimental eﬀects of acute stress on working memory. In a double
blind, randomized, placebo-controlled, between-subjects intervention study, 58 healthy participants were tested
once before and once after a 28-day intervention.
Without stress induction, probiotics did not aﬀect brain, behavioral, or related self-report measures. However,
relative to placebo, the probiotics group did show a signiﬁcant stress-related increase in working memory
performance after supplementation. This change was associated with intervention-related neural changes in
frontal cortex during cognitive control exclusively in the probiotics group. Overall, our results show neuro-
cognitive eﬀects of a multispecies probiotic in healthy women only under challenging situations, buﬀering
against the detrimental eﬀects of stress on cognition.
1. Introduction
Probiotics are deﬁned as bacteria providing health beneﬁts to the
host when consumed in adequate amounts (Hill et al., 2014). In the last
few decades, an increasing number of animal studies have indicated a
role of probiotics in regulating mood, cognition, and response to stress,
via the bi-directional link between the brain and the gut microbiome
(Cryan and Dinan, 2012). For instance, by means of probiotics it was
possible to reduce anxiety-like behavior and to normalize brain-derived
neurotropic factor (BDNF) in the hippocampus of mice with infectious
colitis (Bercik et al., 2011), and to reverse the abnormal stress responses
in germ-free mice (without a gut microbiome) (Sudo et al., 2004). Other
studies showed that probiotics are able to lower levels of systemic in-
ﬂammatory cytokines (McCarthy et al., 2003) and to regulate central
GABA receptor expression in mice (Bravo et al., 2011). Additionally,
probiotics could normalize the immune response, as well as nora-
drenaline concentration in the brainstem of rats after maternal
separation (Desbonnet et al., 2010).
1.1. Eﬀects of probiotics on neurocognitive mechanisms
In humans, six weeks of probiotic supplementation in patients with
intestinal disorders resulted in a decrease of depressive complaints as-
sociated with the intestinal disease, which was related to decreased
brain limbic reactivity to negative emotional stimuli (Pinto-Sanchez
et al., 2017). In healthy humans, four weeks of fermented milk product
supplementation was associated with decreased functional magnetic
resonance imaging (fMRI) responses in aﬀective, viscerosensory, and
somatosensory brain regions during emotional face matching (Tillisch
et al., 2013). However, these latter results should be taken carefully due
to a number of limitations, i.e. group sizes (ranging between 10 and 12
subjects) and probiotics’ eﬀects versus the no-intervention group in-
stead of versus the placebo group. Nonetheless, existing evidence seems
to suggest eﬀects of probiotics on neural emotion reactivity in humans.
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However, emotion reactivity is only one of diﬀerent aﬀective appraisal
processes, which also consist of emotion-speciﬁc regulation and more
generic cognitive control components (Kohn et al., 2014; Etkin et al.,
2015). Thus, although eﬀects of probiotics have been observed only on
neural emotion reactivity, it is possible that this is related to regulation
of emotion or to higher order cognitive control processes.
Therefore, our ﬁrst aim was to investigate whether emotion re-
activity is speciﬁcally aﬀected by probiotics, whether these eﬀects
occur through control of emotion (i.e. regulating automatic biases, see
Etkin et al., 2006; Etkin et al., 2015), or can be seen independent of
emotion (O'Hagan et al., 2017), i.e. aﬀecting cognitive control more
generally. We investigated the eﬀects of a multispecies probiotics
(Ecologic®Barrier) (Van Hemert, 2014), in a randomized, double-blind,
placebo-controlled between-subjects design. This formulation has been
tested before in both animal and human studies. Speciﬁcally, previous
rat experiments showed eﬀects of this formulation on depressive-like
behavior and on the transcript level of factors involved in HPA axis
regulation (e.g. Abildgaard et al., 2017a; Abildgaard et al., 2017b). In a
previous human study in n= 40 healthy participants, 4-weeks supple-
mentation with this product was associated with a reduction in self-
reported cognitive reactivity to sad mood versus placebo (Steenbergen
et al., 2015). Currently, we studied the eﬀects of probiotics on neural
correlates underlying emotion reactivity, its regulation, and general
cognitive control, by using three robust cognitive paradigms during
fMRI: the emotional face-matching task (Hariri et al., 2000), known to
activate the limbic network, including the amygdala, involved in
emotion reactivity; the emotional face-word Stroop task (Etkin et al.,
2006), known to activate regions in ventral and dorsal medial frontal
cortex involved in emotion regulation; and the color-word Stroop task
(Stroop, 1953), known to activate frontal cortex regions involved in
cognitive control (Cieslik et al., 2015).
1.2. Eﬀects of probiotics on cognition: the role of stress
Animal studies have shown how the gut-brain axis is crucial for
stress regulation, by inﬂuencing the development of the hypothalamic-
pituitary-adrenal (HPA) axis, which – in turn – is related to mood,
emotion, and BDNF expression important for learning and memory
(Sudo et al., 2004; Li et al., 2009; Gareau et al., 2011; Frohlich et al.,
2016). The eﬀects of probiotics and stress on cognition might share
common pathways of action (e.g. the HPA axis (Arnsten, 2015; Sarkar
et al., 2016)), however, it is unclear whether probiotics might aﬀect
cognitive performance independent or dependent of the detrimental
eﬀects of stress. Beneﬁcial eﬀects of probiotics under stress conditions
have been clearly demonstrated in animal studies (e.g. Gareau et al.,
2011; Messaoudi et al., 2011; Ait-Belgnaoui et al., 2014; Cowan et al.,
2016), but probiotics’ eﬀects on cognition and stress resilience in hu-
mans are scarce and sometimes contradictory (Allen et al., 2016; Kelly
et al., 2017).
Therefore, as secondary aim, we took into account the possibility
that potential probiotics eﬀects on cognition could exist only as a
consequence of an increased buﬀer against stress. The probiotic product
under investigation, Ecologic®Barrier, is developed to strengthen epi-
thelial barrier function and to decrease intestinal permeability for the
endotoxin lipopolysaccharide (LPS), as demonstrated in vitro (Van
Hemert 2014). Human studies showed that acute-stress paradigms in-
crease intestinal permeability to LPS (Alonso et al., 2012; Vanuytsel
et al., 2014), and detrimentally aﬀect memory performance (Schoofs
et al., 2009). For example, the socially evaluated cold pressor test
(SECPT) (Lovallo, 1975) speciﬁcally inﬂuenced backwards digit span
(DS) performance, which involves control functions to operate on the
stored material instead of just working memory maintenance (Schoofs
et al., 2009). For this reason, we investigated whether the use of pro-
biotics can modulate backwards DS performance before versus after
acute stress induced by the SECPT, together with stress-related changes
in hormones (cortisol and alpha-amylase) and cardiovascular activity.
As the type of cognition we investigated after and before stress – i.e.
backwards digit span - requires cognitive control (Kane and Engle,
2003), we also investigated how intervention-induced eﬀects on this
stress-related working memory performance related to the eﬀects of the
intervention on cognitive control responses in the frontal cortex.
2. Materials and methods
2.1. Participants
In total, ﬁfty-eight of the 61 pre- and post-intervention scanned
participants were included in the analyses, divided into a probiotics
intervention group (n= 29, mean age=21 years, SEM=0.4) and a
placebo group (n=29, mean age=22 years, SEM=0.5). Three par-
ticipants were excluded from the ﬁnal analyses, one due to high de-
pression levels (above BDI cut oﬀ for moderate depression, i.e. BDI
score: 23), and two given poor fMRI-task performance (Supplementary
Materials). All participants were right handed, healthy female volun-
teers aged between 18 and 40 years old, using (oral or intra-uterine)
hormonal contraceptives, with a healthy weight, i.e. a body mass index
(BMI) between 18 and 25 (placebo group: mean BMI= 21.66 kg/m2,
SEM=0.31, and probiotics group: BMI=21.91 kg/m2, SEM=0.29).
They were not in the ‘stop week’ of oral contraceptives during test
sessions to ensure similar hormone levels between both sessions across
participants. Exclusion criteria included: 1) personal history of psy-
chiatric, neurological, gastrointestinal, endocrine disorders, and re-
levant medical history (self-reported); 2) regular medication use; 3)
pre- and probiotic supplementation; 4) smoking; 5) use of antibiotics
within two months before the start of the study. We also excluded those
participants with lactose intolerance, those following a vegan diet, and
those with high alcohol intake (i.e. more than 10 glasses of any alco-
holic drink per week). Participants who changed their diet within three
months of the ﬁrst testing session were also excluded. Furthermore,
participants were screened for MRI compatibility. The study was con-
ducted following the Declaration of Helsinki with human subjects and
the complete procedure was approved by the local Ethics Committee
(CMO Arnhem-Nijmegen, NL55406.091.15) and registered at the Dutch
trial register (protocol number: NTR5845). Written informed consent
was obtained from each participant.
2.2. Intervention
Probiotics (Ecologic®Barrier) and placebo were consumed in powder
form for 28 days in a row, 2 g once daily at a ﬁxed time point, on an
empty stomach by diluting the powder in water or milk (see
Supplementary Materials for bacterial strains). Participants were asked
not to eat for the subsequent 15–20min after the ingestion of the drink.
All participants were randomly assigned to the two groups. The
randomization scheme was computer generated by Winclove using
permuted blocks with block size equal to 4. It was impossible for re-
search personnel involved with participants to adjust randomization or
discern what product participants were receiving, ensuring true allo-
cation concealment.
2.3. Procedure
2.3.1. General procedure
A longitudinal double-blind randomized design was used to com-
pare the eﬀects of probiotics with placebo. Each participant was as-
sessed twice: before the start of the treatment and four weeks later.
Between the test sessions, a 28 days intervention consisting of probio-
tics or placebo intake was implemented. Both test sessions were con-
ducted at the Donders Centre for Cognitive Neuroimaging in Nijmegen,
The Netherlands. Testing was conducted exclusively in the afternoon.
At the beginning of the ﬁrst test session, the experimental procedures
were explained and the principal researcher assessed physical
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measurements, including height, weight, blood pressure, and heart rate
(Fig. 1). Next, participants practiced all the fMRI tasks outside the
scanner, and performed a working memory test (backward and forward
digit span test). Subsequently, the participants took part in the fMRI
experiment (75min), with three cognitive paradigms described below.
After some time to relax after the MRI measurement (i.e. 10–15min),
another trained researcher (unfamiliar to the participant) conducted a
stress task followed by the same working memory test (with diﬀerent
items) as performed before scanning (conducted by the principal re-
searcher again). Saliva and cardiovascular parameters were collected
over the testing sessions (see Fig. 1, and Supplementary Materials). At
the end of the ﬁrst session day, participants were provided with the
probiotics/placebo (in identical sachets, blind to both participants and
researchers) and were informed about how to consume them. Com-
pliance was encouraged with regular reminders (i.e. before, at the be-
ginning, during and at the end of the supplementation period) and a
personal diary (i.e. calendar to keep track of the correct and regular
daily consumption of the product). The same testing procedure was
repeated during the second session day (which took place at the same
time as the ﬁrst session), after the 28-day intervention period (average
number of days between ﬁrst test day and start of supplementation
(SD): 8.5 (5.5); average number of days between end of supplementa-
tion and second test day (SD): 1.5 (0.7)). The second testing day ended
with the written question to the participants on whether they thought
they had taken the placebo or the probiotic, on which they answered by
chance (number of correct answers: 15/29 (51,7%) for the placebo
group and 12/29 (41.4%) for the probiotics group).
2.3.2. Eﬀects of probiotics on neurocognitive mechanisms
2.3.2.1. Questionnaires. Questionnaires were administered using an
Electronic Data Capture (EDC, https://castoredc.com) application for
online data collection. Speciﬁcally, we assessed depression with the
Dutch version of the self-reported Beck Depression Inventory
questionnaire (BDI) (Beck, 1976). Depression sensitivity was
evaluated with the Leiden Index of Depression Sensitivity-revised
questionnaire (LEIDS-r) (Antypa et al., 2010) (Supplementary
Materials), on which the eﬀects of this speciﬁc probiotic product have
been reported previously (Steenbergen et al., 2015). Other
questionnaires were assessed to control for changes in diet and
baseline diﬀerences in psychological traits, but these were not
observed (Supplementary Materials).
2.3.2.2. Task paradigms. The fMRI tasks (Fig. 2) included an emotional
face-matching paradigm, an emotional face-word Stroop paradigm, and
the classic color-word Stroop paradigm. Participants were instructed to
react as fast and accurately as possible during all three tasks. The
experiments were programmed in Presentation® software (Version 0.70,
www.neurobs.com).
2.3.2.2.1. Emotional face-matching paradigm. This paradigm
(Fig. 2a) was chosen to investigate intervention-induced changes in
emotion reactivity. Stimuli were presented in a block design, with a
total of 18 blocks consisting of three stimuli each. The task included a
control and an emotion condition. In the control condition participants
had to match one of two geometric shapes presented at the bottom, to a
target shape presented at the top of the screen. The experimental
condition involved participants choosing one of two emotional (angry
or fearful) faces presented at the bottom of the screen that best matched
the emotional expression of a face seen at the top of the screen. The
condition was kept constant over the block duration of 17 s but was
randomized between blocks. The total duration of the task amounted to
7min.
2.3.2.2.2. Emotional face-word stroop paradigm. A Dutch version of
the emotional face-word Stroop task was used to assess intervention-
induced diﬀerences in the ‘resolution of emotional conﬂicts’ in the face
of emotional distracters (Fig. 2b). During this task, participants were
presented with pictures of male faces expressing fear or happiness. On
top of the faces, the Dutch words for happy (i.e. “blij”) and fearful (i.e.
“bang”) were presented in prominent red letters. The emotions
described by the words were either congruent with the emotion of
the face or incongruent, and participants had to indicate the emotion of
the face by ignoring the emotion word. A total of 148 stimuli of happy
or fearful faces were presented. The order of stimulus presentation was
pseudo-randomized and the total duration of the task added up to
15min.
2.3.2.2.3. Classic color-word stroop paradigm. A Dutch version of the
classic color-word Stroop task was used to assess intervention-induced
diﬀerences in general cognitive control (i.e. resolving response conﬂict)
in the absence of emotional stimuli (Fig. 2c). During this task,
participants were presented with four diﬀerent color words written
either in the same ink color as the word (e.g. red written in red ink) or
in an incongruent color (e.g. red written in blue ink). They were asked
to indicate the ink color of the word by pressing a button mapped to
that color, and to ignore the word meaning. The task consisted of 80
stimulus presentations in total. Color-button mappings were
randomized across subjects but kept constant between the two
sessions of each participant (for both Stroop tasks). The duration of
the task amounted to 10min.
2.3.3. Eﬀects of probiotics on cognition: the role of stress
For stress induction, we used the Socially Evaluated Cold Pressor
Test (Lovallo, 1975). During this test, physical and psychological stress
was induced. Physical stress was induced by having participants im-
merse their hand into ice water (ranging between 0 and 3 °C) for “as
long as possible, until the researcher indicates to pull the hand out of
the water”. Unknown to the participants, the maximal duration was set
at 3min (180 s). The mean duration of ice water immersion was 160.8 s
(SD: 45.6) for the ﬁrst session, and 171 s (SD: 32.4) for the second one.
The test was conducted by a researcher who was yet unknown to the
participant, and who adopted neutral and socially distant behavior to
increase psychological stress. Further psychological stress was induced
by asking participants to look into a video camera during the cold-water
test, with the aim to record their facial expressions. Saliva samples were
collected to evaluate cortisol and alpha-amylase levels in response to
the stressor. A total of ﬁve saliva samples from each participant was
obtained: one sample was obtained 10min before the start of the
SECPT, one sample right before and one sample immediately after the
end of the SECPT, one sample 25min and one sample 45min after the
end of the ice water immersion (see Fig. 1). Parameters reﬂecting
Fig. 1. Overview of the testing sessions.
Each participant was tested twice, before and after 4 weeks of supplementation with probiotics/placebo. The procedure of the two sessions was the same (i.e.
participants performed the same tests in the same order). SECPT: socially evaluated cold pressor test; BP: blood pressure; HR: heart rate; VAS: visual analog scale.
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autonomic nervous system activation, i.e. systolic and diastolic blood
pressure and heart rate (HR) were registered at the beginning of the
test, as well as every time that the saliva samples were collected (plus
one extra measurement between the collection of the second and third
saliva sample). The total score of the visual analog scales (VAS) was
used to assess the subjective feeling of stress and obtained by the sum of
each sub-scale of the VAS: tension, happiness (reversed scored), pain,
fear, irritation, and stress. The VAS questionnaires were completed each
time during saliva collection.
To evaluate stress-related eﬀects in cognitive functioning, we used
the digit span test to assess working memory performance, at the
beginning of the experiment and right after the stress induction (within
a range of 5min from the end of the stress task). Speciﬁcally, during the
digit span test participants listened to a series of numbers and tried to
repeat each series correctly (DS forward) or repeat it backwards (DS
backward). Following a correct response, the participants had to repeat
increasingly longer sequences. Participants performed diﬀerent ver-
sions of the test before and after stress on the ﬁrst and second test day.
Fig. 2. The fMRI paradigms. a) Emotional face-matching task, b) Emotional face-word Stroop task, and c) Color-word Stroop task. The control and the experimental
conditions of each paradigm are represented on the left and right side of the panel respectively. The duration of each stimulus and the relative inter-trial interval are
indicated in ms. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the Web version of this article.)
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2.4. Data analyses
2.4.1. Eﬀects of probiotics on neurocognitive mechanisms
2.4.1.1. Questionnaire analysis. Statistical analyses of the data were
performed using IBM SPSS statistics (version 23.0), and the results were
expressed in terms of mean values and standard errors of the mean
(SEM). The eﬀects of the intervention on questionnaire scores were
analyzed by performing 2×2 repeated-measure ANOVAs for data that
was normally distributed. The ﬁrst factor was ‘Group’ (between-
subjects), with two levels (placebo and probiotics), the second factor
was ‘Session’ (within-subjects), with two levels (pre- and post-
intervention session). For data that was not normally distributed, we
used the Wilcoxon-Mann-Whitney test to assess group diﬀerences on
the post-pre scores.
2.4.1.2. Behavioral analysis of fMRI tasks. We evaluated behavioral
performance during the fMRI tasks before and after the intervention
between the two groups, by analyzing the correct reaction times (RTs).
The analyses were done on log-transformed data to reduce the skewness
of the distributions, which were better normalized after this correction.
We ran a 2× 2×2 repeated-measure ANOVA design, with the factors
Group (between-subjects), Session (within-subjects), and Condition
(experimental vs. control condition, within-subjects).
2.4.1.3. fMRI acquisition and analyses
2.4.1.3.1. MR data acquisition. MR data were acquired using a 3T
MAGNETOM Prisma system, equipped with a 32-channel head coil.
During the three tasks, 3D echo planar imaging (EPI) scans using a
T2*weighted gradient echo multi-echo sequence (Poser et al., 2006)
were acquired (voxel size 3.5×3.5×3mm isotropic, TR= 2070ms,
TE= 9ms; 19.25ms; 29.5 ms; 39.75ms, FoV=224mm). The slab
positioning and rotation (average angle of 14° to AC axis) optimally
covered both prefrontal and deep brain regions (i.e. including aﬀective
brain regions like the amygdala). A whole-brain high-resolution T1-
weighted anatomical scan was acquired using a MPRAGE sequence
(voxel size 1.0×1.0 x 1.0 isotropic, TR= 2300ms, TE=3.03ms, 192
slices).
2.4.1.3.2. MRI data preprocessing. Data was preprocessed and
analyzed using Statistical Parametric Mapping (SPM8) (Wellcome
Department of Imaging Neuroscience, London). Preprocessing steps
included multi-echo combination, slice timing correction,
coregistration of functional and anatomical images, spatial
normalization based on uniﬁed segmentation parameters, and spatial
smoothing (8mm FWHM) (Supplementary Materials).
2.4.1.3.3. fMRI analyses. Fixed eﬀects analyses of the fMRI tasks
are described in the Supplementary Materials.
On the second (group) level, we ﬁrst performed random eﬀect
analyses of variance (ANOVA) in a full-factorial design to obtain the
main task eﬀects (positive and negative) for each task across sessions.
The ANOVA analyses were run with the contrast images speciﬁed in the
ﬁrst level analyses and two additional factors: Group (probiotics and
placebo) as a between subject-factor and Session (pre- and post-inter-
vention session) as a within-subject factor. Subsequently, we ran two-
samples t-test analyses between the probiotics and the placebo group
using the contrast images of Condition x Session speciﬁed at the ﬁrst
level. We considered results signiﬁcant if p < 0.05 Family-Wise-Error
(FWE) whole-brain corrected at cluster level (with a cluster deﬁning
threshold of p < 0.001).
2.4.2. Eﬀects of probiotics on cognition: the role of stress
Using a 2×2×2 repeated-measure ANOVA, we analyzed the
stress-related cardiovascular data, i.e. systolic (BPsys) and diastolic
blood pressure (BPdia), as well as heart rate (HR); hormones, i.e. alpha-
amylase and cortisol; and VAS scores (subjective stress-related feeling).
All the analyses were done on log-transformed data. The ﬁrst factor was
Group, with two levels (placebo and probiotics, between-subjects), the
second factor was Session, with two levels (pre- and post-intervention
session, within-subjects), and the third factor was Time (within-sub-
jects). For the cardiovascular data, the third factor Time consisted of
seven levels (one level for each saliva collection time point (see above)
plus two extra measurements: one at the beginning of the experiment,
and one right before the immersion of the participant's hand in the cold
water box), while for the alpha-amylase, cortisol, and VAS scores the
factor Time consisted of ﬁve levels (one level for each saliva collection
time point; see Fig. 1). Eﬀects of Time indicated an eﬀect of the stressor,
whereas Group*Session interactions indicated eﬀects of probiotic sup-
plementation.
A 2 × 2 × 2 repeated measure ANOVA was also chosen to analyze
probiotics-induced eﬀects (Group*Session interactions) on DS back-
wards after versus before stress induction (within-subjects factor:
Time). Analyses were performed on the raw scores given that the DS
scores were normally distributed.
In the last step of the analysis, we investigated whether individual
diﬀerences in probiotics eﬀects on working memory were associated
with probiotics eﬀects on brain functioning during cognitive control
(i.e. incongruent versus congruent Stroop trials). For this, we extracted
averaged beta weights (MarsBar toolbox of SPM, Brett, 2002) from the
signiﬁcantly (pFWE<0.05) activated regions in frontal cortex during
the Stroop task (Fig. 3f), independent of the intervention. To extract the
average beta values, we applied a sphere of 10mm on the local maxima
of each (sub-)cluster in frontal cortex, to prevent averaging from large
clusters extending across diﬀerent regions. Subsequently, we calculated
post-minus pre-intervention scores of the average beta weights and
correlated these to the intervention eﬀect (post-minus pre-intervention)
in the stress-induced working memory (i.e. DS backward) performance
scores. We performed these ROI analyses per group, such that we could
compare the correlations of the probiotics group to that of the placebo
group using Fisher's r to z transformation.
There were no outliers according to the Grubbs' test for outliers. We
considered results with p < 0.05 signiﬁcant or, with multiple com-
parisons with the same outcome (i.e. correlation of intervention eﬀects
on stress-related working memory in multiple frontal Stroop ROIs),
p < 0.05/number of comparisons (Bonferroni correction). We report
partial eta squared as a measure of eﬀect size.
3. Results
3.1. Eﬀects of probiotics on neurocognitive mechanisms
3.1.1. Questionnaires
We did not observe eﬀects of probiotics on any of the questionnaires
(Table S1, Supplementary Materials). We did not ﬁnd diﬀerences be-
tween the two groups at baseline either, i.e. pre-intervention. Neither
did the groups diﬀer in terms of diet (type, style, or short FFQ) at
baseline, and pre-versus post-treatment (all p > 0.1) (Table S2, Sup-
plementary Materials).
3.1.2. RT results
First, we assessed whether the task behavior independent of the
intervention was as expected. Indeed, participants were signiﬁcantly
slower in each experimental condition of the three tasks (all
p < 0.001), indicating emotional and cognitive control processes en-
gagement compared with the control condition (see Table S3, Supple-
mentary Materials and Fig. 3a, c, and e). However, we did not observe
eﬀects of probiotics versus placebo on any of the three tasks, i.e., no
signiﬁcant Group x Session x Condition eﬀects were found (all
p > 0.05, all ηp2< 0.005). There were no signiﬁcant group diﬀerences
at baseline, i.e. pre-intervention, either (all p > 0.05).
3.1.3. Neuroimaging results
Similar to the behavioral results, we ﬁrst assessed - independent of
the intervention - whether the three tasks activated the anticipated
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brain regions. The main task eﬀects of the three fMRI tasks were as
expected and are shown in Fig. 3b, d, and f, and reported in Table S4
(Supplementary Materials) at pFWE<0.05 (whole-brain correction at
cluster level). The emotional face-matching task activated, amongst
others, the bilateral amygdala. We observed responses to the emotional
face-word Stroop task in regions such as the medial frontal cortex (pre-
SMA), vmPFC and lateral PFC (lPFC). Clusters activated for the color-
word Stroop task included the lPFC and medial frontal cortex.
We subsequently assessed the eﬀects of probiotics versus placebo
(pre vs. post intervention) on each of the three fMRI tasks. At our
whole-brain corrected threshold of pFWE< 0.05 (cluster level), we did
not observe any eﬀects of probiotics during the three fMRI tasks.
3.2. Eﬀects of probiotics on cognition: the role of stress
3.2.1. Stress-induced working memory performance
Signiﬁcant eﬀects of Time revealed that the stressor had eﬀects on
physiological and subjective measures of stress (all p < 0.05) see
Fig. 4a and b. However, the intervention did not aﬀect these physio-
logical and subjective measures of stress (Group x Session×Time in-
teractions for HR, BPsys, BPdia, hormones, and VAS: p > 0.05) (Sup-
plementary Materials).
However, we did ﬁnd that stress-induced working memory perfor-
mance in DS backward (see Table S5, Supplementary Materials) was
diﬀerentially aﬀected by the probiotics (post vs. pre) versus placebo
(post vs. pre), evidenced by a Time(2) x Group(2) x Session(2) inter-
action (F(1,56)= 4.48, p=0.039, ηp2= 0.07). Breaking this interac-
tion eﬀect down into simple eﬀects, we observed that the probiotics
(post vs. pre) tended to increase stress-induced backward digit span
performance (Time(2) x Session(2), probiotics: F(1,28)= 4.1,
p=0.053, ηp2= 0.127), whereas no signiﬁcant post-pre intervention
eﬀect was observed in the placebo group (Time(2) x Session(2), pla-
cebo: F(1,28)< 1, p=0.36, ηp2= 0.03) (Fig. 5). In sum, probiotics
versus placebo supplementation resulted in a buﬀer against the detri-
mental eﬀect of stress on control-demanding working memory.
The two groups diﬀered marginally at baseline (i.e. pre-intervention
diﬀerences in the eﬀect of stress on DS backwards, Time(2) x Group(2):
F(1,56)= 3.24, p=0.077, ηp2= 0.05), with the placebo group
showing no detrimental eﬀects of stress on working memory at baseline
(PRE, eﬀect of Time: t(1,28)=−1.27, p=0.21), in contrast to nu-
merically opposite, but also non-signiﬁcant, eﬀects in the probiotics
group (PRE, eﬀect of Time: t(1,28)= 1.29, p= 0.21) (see Discussion).
3.2.2. Correlations between neural cognitive control responses and stress-
induced working memory eﬀects
In the probiotics group, we found signiﬁcant negative correlations
between the intervention eﬀect on the neural color-word Stroop re-
sponses (i.e. averaged incongruent-congruent betas) and the interven-
tion eﬀect on the stress-related diﬀerence scores in DS backwards in all
three independent frontal ROIs (see Table S4, Supplementary Mate-
rials): left lPFC (BA45) (x,y,z: 42, 20, 24): r=−0.52, p= 0.004; pre-
SMA (x,y,z: 6, 2, 60): r=−0.38, p=0.04; right lPFC (BA44) (x,y,z:
48, 6, 30): r=−0.60, p < 0.001 (Fig. 6). However, in contrast to the
two lPFC regions, the association in pre-SMA was not signiﬁcant after
correction for multiple comparisons (p > 0.017). See Supplementary
Materials for the fronto-striatal responses observed in the whole-brain
Fig. 3. Main task eﬀects.
Signiﬁcant main task eﬀects independent of the intervention (i.e. across groups and sessions) in behavioral data (on the left; * = p < 0.001) and fMRI data (on the
right; thresholded at pFWE<0.05 [cluster deﬁning threshold: p < 0.001]) for a) the emotional face-matching paradigm in RTs and b) in brain (hot colors:
emotion > shape; cold colors: shape > emotion); c) the emotional face-word Stroop paradigm in RTs and d) in brain (hot colors: incongruent > congruent; cold
colors: congruent > incongruent); e) the color-word Stroop paradigm in RTs and f) in brain (hot colors: incongruent > congruent). (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the Web version of this article.)
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correlation within the probiotics group (Table S6; Fig. S1). These brain-
behavior correlations were not found in the placebo group (left lPFC
(BA45): r=−0.21, p= 0.27; pre-SMA: r=−0.19, p=0.32; right
lPFC (BA44): r= 0.03, p= 0.89) (Fig. 6). Importantly, we subsequently
assessed whether the brain-behavior correlations were signiﬁcantly
diﬀerent between the probiotics and placebo group. Indeed, the inter-
vention with probiotics resulted in a greater association between
changes in stress-related working memory and neural cognitive control
responses in the right lPFC than the placebo intervention (Fisher's r to z
transformation, z=−2.61, p=0.009). In contrast to the right lPFC,
the correlation coeﬃcients between the probiotics and placebo groups
did not signiﬁcantly diﬀer from each other in the left lPFC (z=−1.31,
p=0.19) or in the pre-SMA (z=−0.75, p=0.45).
In sum, the probiotics' intervention eﬀect (post-pre) on stress buﬀer
during working memory was especially evident in those subjects with
probiotics’ induced decreases in prefrontal cortex recruitment during
cognitive control.
4. Discussion
We aimed to investigate the eﬀects of multi-species probiotic sup-
plementation on neurocognition in healthy human volunteers. For our
ﬁrst aim, we assessed whether the neurocognitive eﬀects of probiotics
versus placebo would only be seen on emotion reactivity to negative
stimuli or also on emotion regulation or general cognitive control. In
our secondary aim, we investigated whether the eﬀects of probiotics on
Fig. 4. Physiological and psychological stress eﬀects.
a) Physiological and psychological raw data during the SECPT (onset at time=0, dotted vertical line), i.e. blood pressure (BP) systolic (top-left panel), blood
pressure (BP) diastolic (top-right panel), heart rate (HR) values (bottom-left panel), and total VAS score (bottom-right panel) and b) Hormone levels during the
SECPT, i.e. cortisol values (left panel), and alpha-amylase values (right panel), for the two groups (probiotics and placebo), before and after the intervention period.
Fig. 5. Stress-induced changes in working memory.
Stress-induced working memory scores (calculated as the diﬀerence of DS
backwards scores after stress minus scores before stress) obtained pre- and post-
intervention for the placebo and for the probiotics group. * = p < 0.05;
# = p < 0.1; ns = p > 0.1.
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cognition (i.e. working memory) and associated neural control me-
chanisms were visible only with stress induction. Four weeks of pro-
biotic supplementation did not result in diﬀerences relative to placebo
in terms of neural or behavioral responses during emotion reactivity,
emotion regulation or cognitive control. However, the groups did diﬀer
in their cognitive response to an acute stressor; i.e., the probiotics group
showed an increased buﬀer against the negative eﬀects of stress on
working memory performance relative to placebo. This eﬀect was
especially seen in individuals with probiotic-induced decreases in pre-
frontal cortex recruitment during cognitive control and this association
diﬀered signiﬁcantly from the one in the placebo group.
All three fMRI paradigms robustly activated the expected brain re-
gions and showed the expected behavioral eﬀect (see Fig. 3). Speciﬁ-
cally, emotion reactivity was seen for instance in the amygdala and in
terms of longer RTs for the faces than the shapes during emotional face
matching (Hariri et al., 2000; Haxby et al., 2000), while emotion reg-
ulation and general cognitive control was observed in frontal regions
and in longer RTs for the incongruent trials during the two Stroop tasks
(Etkin et al., 2006; Aarts et al. 2008, 2009; Roberts and Hall, 2008;
Cieslik et al., 2015). However, we did not ﬁnd signiﬁcant eﬀects of
probiotic supplementation on the behavioral (i.e. RTs) and neural re-
sponses to the tasks, in line with the results on the questionnaires. This
contrasts with previous ﬁndings in healthy controls, using the same
probiotic product, which indicated a probiotics-induced decrease in
cognitive reactivity to sad mood using the LEIDS-r questionnaire
(Steenbergen et al., 2015). However, when comparing the baseline
scores on the depression-related questionnaires, i.e. LEIDS-r and BDI,
we note that our participants scored much lower (i.e. across groups,
mean LEIDS-r total: 25.1; mean BDI: 2.4) than the participants of
Steenbergen and colleagues (i.e. across groups, mean LEIDS-r total:
43.7; mean BDI: 8.5).
Recently, a study in IBS patients also found a probiotics-induced
reduction of depressive symptoms as well as a reduction in neural
emotion reactivity using fMRI, but these patients had mild to moderate
depression at baseline (i.e. across groups, mean HADS-depression: 10.5)
(Pinto-Sanchez et al., 2017). Accordingly, studies assessing probiotics’
eﬀects in participants with at least some degree of depression at base-
line (i.e. across groups, median HADS-depression: 5.5) (Messaoudi
et al., 2011) or in patients with major depressive disorder (Akkasheh
et al., 2016) have reported positive eﬀects on depression scales. In line
with our results, the sample of Tillisch et al. (2013) scored low on de-
pression (i.e. across groups, mean HADS-depression: 1.3) and they did
not observe diﬀerences between the placebo and probiotics group on
self-report or neural measures of emotion reactivity (neural diﬀerences
were only observed for a less controlled comparison between probiotics
and no intervention). Similarly, another study with a healthy sample
with low depression ratings (mean BDI at baseline: 3.92) did not ﬁnd
probiotics-induced changes in cognition or resting EEG (Kelly et al.,
2017). Healthy individuals are known to exhibit a diﬀerent gut-mi-
crobiome composition relative to individuals suﬀering from depression
(Jiang et al., 2015; Kelly et al., 2016). Thus, based on our current and
on previous results, it seems that probiotics only have eﬀects on self-
report and neural measures of emotion and cognition if subjects are
either clinically aﬀected or score high in diagnostic questionnaires,
suggesting limited beneﬁcial eﬀects of probiotics on mood and neuro-
cognition in healthy individuals as in the current study.
However, a study using Biﬁdobacterium longum 1714, did demon-
strate (within-subject) probiotic-induced beneﬁcial eﬀects on associate
learning and changes in resting EEG in 22 healthy, non-depressed in-
dividuals (i.e. mean BDI at baseline: 3.6) (Allen et al., 2016). The same
strain was able to reduce anxiety and depression-like behavior in an-
xious BALB/c mice (Savignac et al., 2014). Moreover, a recent MRI
study, with a slightly diﬀerent multispecies probiotic, demonstrated
eﬀects of 4-weeks probiotics supplementation on resting state func-
tional and structural connectivity (Bagga et al., 2018a,b), as well as on
associated but diﬀerent neural mechanisms of emotional processing
(i.e. emotional memory and emotional decision-making processes)
(Bagga et al., 2018a,b). The sample of these two studies also consisted
of non-depressed individuals (i.e. across groups, mean LEIDS-r total:
29.8), but each group only had 15 participants, so results should be
interpreted with caution. Nevertheless, in addition to the presence of a
certain degree of depressive/anxiety symptoms, other factors such as
type of bacterial strains might play a role in observing beneﬁcial neu-
rocognitive eﬀects of probiotics. Therefore, future studies should in-
vestigate the mechanisms of action of single bacterial strains to un-
derstand their potential in beneﬁtting mood and cognition in diﬀerent
human populations.
The second aim of the present study was to investigate whether
probiotics can have a beneﬁcial eﬀect on cognition by buﬀering against
stress. The ﬁnding that probiotic supplementation did aﬀect working
memory performance, as a function of stress, is in line with preclinical
work emphasizing the role of gut microbiota and probiotics in stress-
related disorders (Kelly et al., 2015). For example, in mice with a
bacterial infection, acute stress caused memory impairments, which
were ameliorated by probiotics (Gareau et al., 2011). Moreover, Biﬁ-
dobacterium longum was able to improve learning and memory in mice
with high susceptibility to stress (Savignac et al., 2015). Based on our
results, we hypothesize that in healthy young individuals, probiotics
might especially induce beneﬁcial eﬀects on cognition and brain
functioning only when the system is challenged by stress. However,
caution is warranted due to trending baseline diﬀerences in our sample.
The placebo group as a whole seemed to demonstrate (non-
Fig. 6. Brain-behavior correlations.
Correlations between the intervention eﬀect on stress-induced working memory (WM) diﬀerence scores (digt span backwards scores after stress minus digit span
backwards scores before stress, post-pre intervention) and the intervention eﬀect on cognitive control-related brain responses (i.e. averaged beta values for in-
congruent-congruent color-word Stroop trials, post-pre intervention) for each independently selected frontal ROI (see Fig. 3f and Table S4), i.e. from left to right: left
lateral PFC (BA45), pre-SMA, and right lateral PFC (BA44) for the placebo (grey dots) and for the probiotics group (black dots).
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signiﬁcantly) reduced detrimental eﬀects of stress on working memory
relative to the probiotics group at baseline, which could have resulted
in ceiling eﬀects, i.e. not enough room for improvement.
Critically, we also found stress-related probiotics eﬀects in-
dependent of this marginal baseline diﬀerence between the groups.
Speciﬁcally, the buﬀer against stress-induced detriments in working
memory in the probiotics group was especially seen in individuals with
probiotics-induced changes in frontal brain regions during incongruent
versus congruent trials in the Stroop task. The lack of brain-behavior
correlations between stress-induced working memory and cognitive
control brain responses in the placebo group cannot easily be explained
by ceiling eﬀects given the focus on individual diﬀerences. Individual
working memory capacity is known to be predictive of Stroop perfor-
mance (Kane and Engle, 2003). Here, increases in probiotics-induced
protection against stress eﬀects on working memory were related to
probiotics-induced decreases in frontal cortex recruitment during cog-
nitive control. This might indicate that the protective eﬀects of pro-
biotics against stress are associated to a certain level of optimization in
cognitive control processes. In cognitive control tasks, such as the color-
word Stroop task, the frontal cortex is generally more recruited with
increasing diﬃculty. Diminished frontal cortex responses in the absence
of behavioral changes have previously been interpreted as more eﬃ-
cient frontal cortex functioning (see also e. g. Mattay et al., 2003).
Importantly, we did not observe signiﬁcant correlations in the placebo
group, and the eﬀects in the right lPFC were signiﬁcantly greater in the
probiotics than in the placebo group. This means that the brain-beha-
vior association with stress–related working memory was speciﬁc to the
probiotics treatment and could not be present due to general factors
that would change post-versus pre-intervention for both groups, such as
those related to practice.
Nevertheless, the biological mechanisms behind these eﬀects re-
main to be elucidated, particularly as the beneﬁcial eﬀects of probiotics
on stress-related cognition were not accompanied by probiotics-induced
changes in HPA-axis (i.e. cortisol) or sympatho-adreno-medullary
system (i.e. alpha-amylase) markers. The cardiovascular, hormonal,
and psychological measures of stress indicated that stress was reliably
induced, but were themselves not inﬂuenced by the probiotics, which is
in line with previous studies (Mohammadi et al., 2016; Kelly et al.,
2017; Moller et al., 2017) but see (Allen et al., 2016). If the current
multi-species probiotic product indeed strengthened epithelial barrier
function, as demonstrated in vitro (Van Hemert 2014), then other me-
chanisms could underlie the currently observed eﬀects. Stress can in-
crease the permeability of the intestinal barrier and subsequent immune
reactions to LPS crossing the barrier. Indeed, acute stress paradigms can
increase levels of the cytokine interleukin-6 in healthy human volun-
teers (Treadway et al., 2017). Moreover, multi-species probiotics have
been shown to reduce inﬂammatory markers in depressive patients
(Akkasheh et al., 2016) and in patients with type 2 diabetes (Asemi
et al., 2013). In reaction to increased levels of LPS, pro-inﬂammatory
cytokines can enter the central nervous system and negatively inﬂuence
brain processes involved in memory and learning (Sparkman et al.,
2006; Rogers et al., 2016). Working memory is particularly modulated
by signaling of the neurotransmitter dopamine in frontal and striatal
brain regions (Cools and D'Esposito, 2011), and dopamine neuro-
transmission is aﬀected by stress (Bliss et al., 1968; Arnsten and
Goldman-Rakic, 1998). Hence, acute stress is generally known to be
detrimental to working memory performance and working memory-
related brain responses in PFC, particularly in tasks requiring modula-
tion of information in working memory, such as the digit span back-
ward (Schoofs et al., 2009). Increases in inﬂammatory tone in the body
can induce neuro-inﬂammation, which can particularly aﬀect dopa-
mine signaling, as shown in humans and in non-human primates (Felger
and Treadway, 2017). Probiotics might increase the buﬀer against
stress-induced reductions in dopamine-dependent working memory
performance by decreasing (stress-induced) permeability of the in-
testinal barrier, reducing blood concentration of LPS, and reducing
brain levels of pro-inﬂammatory cytokines, as shown previously in rats
(Ait-Belgnaoui et al., 2012).
An alternative mechanism of the probiotics-induced beneﬁcial ef-
fects might be through the production of metabolites. For example, the
gut microbiome has the potential to synthesize precursors of the
monoamine neurotransmitters (i.e. large neutral amino acids) that
could enter the blood stream, cross the blood-brain barrier, and aﬀect
neurotransmitter release (Lyte, 2013; Sampson and Mazmanian, 2015).
We have recently demonstrated that predicted microbial potential to
synthesize phenylalanine, a precursor of dopamine, was associated with
neural responses during reward anticipation (Aarts et al., 2017), a
function that is also typically modulated by dopamine (Knutson and
Gibbs, 2007). The inﬂuence of the gut microbiome on central dopamine
processing is also evident from germ-free mice, who exhibit increased
turnover of dopamine in the brain (Diaz Heijtz et al., 2011). Future
studies should investigate the potential mechanisms of probiotics in
aﬀecting central neurotransmitter release, e.g. by precursor production,
but also by short chain fatty acid production, or by signaling on enteric
nerve cells and the vagus nerve (Mally et al., 2004; DeCastro et al.,
2005; Sampson and Mazmanian, 2015).
5. Limitations
Our study presents some limitations. First, to avoid potential con-
founding factors on probiotics eﬀects, we focused on female partici-
pants only. This represents a limit for the generalization of the results to
the male population. Secondary, given that the compliance was en-
couraged with regular reminders and a personal diary, the objective
presence of the bacteria was not conﬁrmed via stool sample analysis.
However, analysis from prior studies using the same products con-
ﬁrmed the presence of the bacterial strains in the stool of healthy vo-
lunteers (Koning et al., 2008).
6. Conclusions
We showed that 4-weeks of supplementation with probiotics posi-
tively aﬀected cognition under challenging situations induced by acute
stress, which was associated with changes in frontal brain regions
during cognitive control. However, on neurocognitive tasks adminis-
tered in relative neutral situations we did not observe eﬀects of pro-
biotics across the group. Our ﬁndings of stress-dependent beneﬁcial
eﬀects of probiotics on cognition can be of clinical importance for
stress-related psychiatric and gastro-intestinal disorders.
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